RxDoctor Payments DataLook up a doctor →

Sridhar Durbhakula, MD

Adult Reconstructive Orthopaedic Surgery · Bethesda, MDNPI 1053400366

Payments from drug & device makers

$874,107in general payments, 2019–2025

Across 211 payments — averaging $4142.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthalign Inc$292K
  • Maxx Orthopedics, Inc.$285K
  • Encore Medical, LP$221K
  • Zimmer Biomet$72K
  • Olympus America Inc.$4K
  • Medtronic$244
  • plus $227 from 5 others
$9,000in research payments, 2019–2025

Across 2 payments — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$9K

What the payments were for

  • Royalty or licence$161,41721%
  • Consulting fees$109,37514%
  • Speaking & faculty fees$93,30012%
  • Travel & lodging$15,7302%
  • Food & beverage$12,8572%
  • Education$147,90019%
  • Other$224,93929%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$874,107 in reported general payments places this provider in the 90th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$998,651
Medicare patients
1,289
Services billed
7,961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib93$1,640
Diclofenac Sodium98$1,060
Meloxicam171$730
Cyclobenzaprine Hcl95$725
Oxycodone Hcl122$599
Methylprednisolone77$550
Diclofenac Sodium ErDiclofenac Sodium11$394
Tramadol Hcl94$266
Cephalexin14$215
Amoxicillin79$129
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$117
Acetaminophen-CodeineAcetaminophen With Codeine14$110
Clindamycin Hcl21$38

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →